RNAi-technology
[ Go to bottom | Go to latest post | Subscribe to this topic | Latest posts first ]
RNAi-technology
from WendyWilson1 on 12/30/2022 06:55 AMAs a leading provider of gene silencing service, Baseceuticals is proud to offer high quality RNAi service for customers worldwide. Our talented researchers have established a mature and comprehensive platform to develop the advanced technologies to offer the reliable results at the most competitive price. We have assembled a professional research team with years of experience and wealthy knowledge in RNAi. We will put forward the best strategy for your projects after communication of the specific situation. At Baseceuticals, we are working with you closely to rapidly move forward the projects. RNAi-technology https://baseceuticals.creative-biogene.com/gene-therapy/rnai-service.html
ReplyRe: RNAi-technology
from WendyWilson1 on 12/30/2022 06:56 AMBaseceuticals is a leading biotechnology company which has expertise in providing antisense oligonucleotide service for customers worldwide based on our mature experimental platform. We hold advanced equipment, first-class technologies and experienced scientific researchers, which are ready to offer you the high-quality and professional services with the most reasonable price. Our service will begin at the free consultation to analyze the specific situation and propose the best strategies for your projects. Our dedicated researchers will provide the technical support during the entire process. We have confidence in offering the satisfactory service according to your various requirements and assist you in accelerating the project progress. ASO service https://baseceuticals.creative-biogene.com/gene-therapy/antisense-oligonucleotide-service.html
Re: RNAi-technology
from WendyWilson1 on 12/30/2022 06:56 AMWhooping cough (Pertussis) is an acute respiratory infectious disease caused by Bordetella pertussis. The course of the disease is several months. After the invasion of Bordetella pertussis into the respiratory, it reproduces and releases endotoxins in the cilia of the respiratory, causing inflammation. The symptoms of the patient are dyspnea, paroxysmal spastic cough, and accompanied by deep "cock-crow" inspiratory roar, which may be complicated by pneumonia, neurological diseases, etc. Whooping Cough screening https://corelab.creative-biogene.com/whooping-cough.htm
Re: RNAi-technology
from WendyWilson1 on 12/30/2022 06:56 AMZika virus is spread through mosquito bites, and symptoms after infection are similar to dengue fever, including fever, rash, joint pain, headache, and conjunctivitis. Only about 20% of people infected with Zika virus will show mild symptoms, and those symptoms usually disappear in less than a week. However, if a pregnant woman is infected, the fetus may be affected, leading to neonatal microcephaly and even death. Zika Virus Infection screening https://corelab.creative-biogene.com/zika-virus-infection.htm
Re: RNAi-technology
from WendyWilson1 on 12/30/2022 06:56 AMGenetic disorder is a disease caused in whole or in part by a change in the DNA sequence away from the normal sequence. It can be caused by a mutation in a single gene (monogenic) or multiple genes (polygenic) or by a chromosomal abnormality. Most genetic disorders cannot be cured or even ameliorated using conventional methods of treatment. RNA targeting is emerging as a powerful alternative to conventional therapies for the treatment of genetic disorders. ASO-mediated exon skipping https://integraterna.creative-biogene.com/application/genetic-disorder-therapeutics.html